TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NEUROTECH

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

NEUROTECH

ST13

US500000098448985

Class

5, 10

Filing

98448985

Registration

8233485

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

04/28/2026

Classification

Registered

Trademark type

Combined

Nice classes

5, 10

Filing date

03/14/2024

Registration date

04/28/2026

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/28/2026

Last transaction

04/28/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/04/2025

First use in commerce

06/04/2025

Drawing code

3

Owner type

03

Owner location

Cumberland, RI, US

Examiner

SCHLEGELMILCH, JONATHON A

Law office

L80

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word NEUROTECH to the right of a stylized eye.

Holders and representatives

Holders

Neurotech Pharmaceuticals, Inc.

Representatives

Emilia F. Cannella Ropes & Gray LLP

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the prevention and treatment of ophthalmic diseases and disorders; intravitreal implants, namely, implantable drug delivery devices sold filled with a pharmaceutical for the treatment of eye and vision conditions

Class 10

Medical devices for the prevention and treatment of ophthalmic diseases and disorders; medical device, namely, intraocular implant

Publications

History of USPTO decisions and trademark events.

26 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/28/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

04/28/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

04/07/2026

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

04/07/2026

SUPC

STATEMENT OF USE PROCESSING COMPLETE

04/03/2026

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

04/03/2026

IUAF

USE AMENDMENT FILED

10/07/2025

EISU

TEAS STATEMENT OF USE RECEIVED

10/07/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/27/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/01/2025

PUBO

PUBLISHED FOR OPPOSITION

04/01/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/26/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/05/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

03/05/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/05/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

03/05/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/05/2025

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

12/12/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

12/12/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/26/2024

GNRT

NON-FINAL ACTION E-MAILED

09/26/2024

CNRT

NON-FINAL ACTION WRITTEN

09/26/2024

DOCK

ASSIGNED TO EXAMINER

09/24/2024

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

08/06/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/06/2024

NWAP

NEW APPLICATION ENTERED

03/14/2024

Continuous trademark protection

Get notified about every new filing that threatens NEUROTECH or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.